Maria Sharapova's drugs ban and her public reaction to the suspension do serious damage to her image and long-term prospects, PR professionals told PRWeek UK today - but another sponsorships expert still argues that the Russian's partner brands should not be too hasty to end their relationship with her.
Sharapova had announced in March that she had tested positive for a banned substance, meldonium, which she had been taking on advice from a doctor for several years, but which had since been put on the banned list. She was praised for the way she proactively controlled the message in her initial announcement – and her racquet supplier Head said she had been "courageous" when it announced its decision to continue working with her.
Yesterday, her two-year ban was announced by the International Tennis Federation (ITF) following a hearing last month. Sharapova shared her reaction on her Facebook page.
David Alexander, MD of Calacus PR and a former sports writer for various UK papers, points out that this statement does not mention her legal argument – revealed in the ITF judgement – that a ban would cause the former world number one "a very substantial loss of earnings and sponsorships, exclusion from the 2016 Olympics, and irreparable damage to her reputation".